SCHEMBL29511331

SCHEMBL29511331

c1cc2nc3occc3cc2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 6/20 0.41
CDK9 P50750 1/20 0.35
CYP2A6 P11509 3/20 0.34
KDM4E B2RXH2 2/20 0.34
TUBB4A P04350 1/20 0.34
TUBB P07437 1/20 0.34
TUBA3C P0DPH7 1/20 0.34
TUBA1B P68363 1/20 0.34
TUBA4A P68366 1/20 0.34
TUBB4B P68371 1/20 0.34
TUBB3 Q13509 1/20 0.34
TUBB2A Q13885 1/20 0.34
TUBB8 Q3ZCM7 1/20 0.34
TUBA3E Q6PEY2 1/20 0.34
TUBA1A Q71U36 1/20 0.34
TUBA1C Q9BQE3 1/20 0.34
TUBB6 Q9BUF5 1/20 0.34
TUBB2B Q9BVA1 1/20 0.34
TUBB1 Q9H4B7 1/20 0.34
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15834785 1.00 DYRK1A (0.41) DYRK1ACDK9CYP2A6KDM4ETUBB4A
SCHEMBL10885246 0.73 KDM4E (0.37) DYRK1AKDM4ETUBB4ATUBBTUBA3C
SCHEMBL3130938 0.72 ALDH1A1 (0.56) KDM4EACHEHSD17B10
SCHEMBL2883909 0.72 MAPT (0.56) DYRK1AKDM4EACHEHSD17B10
SCHEMBL30553654 0.72 ALDH1A1 (0.56) KDM4EACHEHSD17B10
SCHEMBL2149910 0.70 CYP2A6 (0.54) DYRK1ACDK9CYP2A6KDM4ECYP3A4
SCHEMBL15834790 0.68 DYRK1A (0.37) DYRK1A
SCHEMBL11336569 0.67 ALDH1A1 (0.36) DYRK1AKDM4ECYP3A4CYP2D6NFKB1
SCHEMBL4137601 0.67 DYRK1A (0.42) DYRK1ACDK9CYP2A6KDM4ECYP3A4
SCHEMBL17086914 0.66 CYP2A6 (0.56) DYRK1ACDK9CYP2A6KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114437096-A Spiro-heterocyclic compound, and preparation method and application thereof 上海医药集团股份有限公司 2022-05-06 CN disclosed